Scientists have said they are a step closer to finding the first effective treatments for the Ebola virus after two potential drugs showed survival rates of as much as 90 percent in a clinical trial in the Democratic Republic of the Congo.
Two experimental drugs – Regeneron’s REGN-EB3 and a monoclonal antibody called mAb114 – were both developed using antibodies harvested from survivors of the Ebola virus.
They showed better results in patients in a trial of four potential treatments being conducted during the world’s second-largest Ebola outbreak in history, now entering its second year in the DRC.
Al Jazeera’s Sara Khairat reports.
– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/